Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Oncare

Mexico City, Mexico City, MexicoNot linked to an institution yet

3running trials
0closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Active, not recruiting
Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab
NCT06211036· Phase 3· Source
Active, not recruiting
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774· Phase 3· Source
Active, not recruiting
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
NCT05740566· Phase 3· Source

Researchers

No researcher is linked here yet.

Site data: ClinicalTrials.govUpdated 8 Nov 2026

Report an error

Under construction, not live – Oncare: trial site – Frontlight Research